Pilot study of pirinixil (BR 931) in various forms of hyperlipoproteinemias.
D000368:Aged; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D013853:Thioacetamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D011743:Pyrimidines; D014280:Triglycerides; D013853:Thioacetamide; C016908:pirinixil; D002784:Cholesterol